Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials
- 1 September 1989
- journal article
- research article
- Published by Springer Nature in Albrecht von Graefes Archiv für Ophthalmologie
- Vol. 227 (5) , 421-427
- https://doi.org/10.1007/bf02172892
Abstract
Pattern electroretinograms (P-ERGs) and pattern visual evoked potentials (P-VEPs) were recorded at three luminance levels and five different check sizes in a group of 16 control subjects before and after the oral administration of levodopa. At the lower luminance levels, significant decrease in P-ERG and P-VEP latencies were found. For P-VEPs the latency changes occurred only at small check sizes. No changes were observed in control experiments without levodopa administration. Our results show that levodopa-induced changes even occur at the retinal level and support a dopaminergic involvement in light and dark adaptation. Our observations are in agreement with a VEP delay found in Parkinson's disease and with a VEP latency increase in rats after dopamine depletion.This publication has 34 references indexed in Scilit:
- Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- VEP changes in Parkinson's disease are stimulus dependent.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Effects of Light on Dopamine Metabolism in the Chick RetinaJournal of Neurochemistry, 1983
- Dopaminergic neurons in the human retinaJournal of Comparative Neurology, 1982
- Cognition in Parkinson disease: An event‐related potential perspectiveAnnals of Neurology, 1982
- Pattern evoked retinal response (PERR) in human: effects of spatial frequency, temporal frequency, luminance and defocusCurrent Eye Research, 1982
- Visual and auditory evoked responses in patients with Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Light Stimulates Tyrosine Hydroxylase Activity and Dopamine Synthesis in Retinal Amacrine NeuronsScience, 1978
- Antiparkinsonian Drugs Pharmacological and Therapeutic AspectsDrugs, 1972
- The inhibition of retinal ganglion cells by catecholeamines and ?-aminobutyric acidPflügers Archiv - European Journal of Physiology, 1969